A commentary from Lewis S. Blevins Jr. M.D. – Dr. Lewis Blevins reviews a recent article published by Mohyeldin and others from Stanford University in Scientific Reports.
Acromegaly
Acromegaly is usually caused by a noncancerous tumor. Middle-aged adults are most commonly affected. Symptoms include enlargement of the face, hands, and feet. Prompt treatment is needed to avoid serious illness. Drugs can reduce the effects of growth hormone. If needed, surgery and radiation may be used to remove tumor cells.
The challenge of early diagnosis in acromegaly. We can do this!
May 18, 2020
Podcast and Survey: Clinical features of acromegaly. In this podcast, Dr. Blevins dives into those clinical features of Acromegaly with a fascinating discussion about symptoms and signs and gives us an unfettered glimpse into the
From Endocrine Web: New Oral Acromegaly Treatment Has No Needles Required
May 14, 2020
From the editors’ desk – A recent Endocrine Web article by Kimberly B. Bjugstad Ph.D. highlights a new oral octreotide drug for Acromegaly. The drug currently is on an FDA Phase III trial, referred to as OPTIMAL,
Critical COVID-19 information for pituitary patients
April 18, 2020
We caught up with Dr. Kevin Yuen, medical director of the Barrow Pituitary Center and the Barrow Neuroendocrinology Clinic in Phoenix, Arizona, and Dr. Lewis Blevins Medical Director of the California Center for Pituitary Disorders at
Survey: What is it like to live with Acromegaly?
March 26, 2020
Your insights matter. From J D Faccinetti – co-founder and chief editor – In the awareness business coming up with new, fresh, creative ideas is essential to get your message across, particularly these days when breaking
6. The clinical trial process in new drug development
March 17, 2020
Dr. Alan Krasner, Chief Medical Officer, and Dr. Chris Cook, Medical Director, Endocrinology at Crinetics Pharmaceuticals offer an in-depth look at clinical studies. In this podcast, we cover a promising molecule – CRNOO808 – under
Real life stories told by people living with Acromegaly
February 27, 2020
A few weeks ago, Dan Jeffreys, a UK based author, musician, and patient advocate sent me a message to tell me about his latest project. He told me he started AcroTales to encourage people to share their
Canada 2019 International Conference Videos available for viewing
February 4, 2020
As we reported a few months back, the Canadian International Acromegaly conference offered exciting presentations and discussions. If you have acromegaly, have a family member that suffers from the disease, or you are a healthcare
3. Giving patients a place at the table
January 31, 2020
The third podcast in our series on drug development touches on the effort that industry is making to partner with patients to understand needs, preferences, and attitudes, and to develop insights that would result in
1. Exploration, Innovation and Creativity: An intimate look at new drug development in the world of pituitary and neuroendocrine disease
January 13, 2020
This is the first in a series of 6 podcasts on the ins and outs of drug development. In it, we discuss the journey that a promising molecule takes to develop into a life-saving medication and
FDA meeting focuses on Acromegaly
January 10, 2020
We are thrilled to announce that Acromegaly will be the focus of a PFDD (Patient-Focused Drug Development) meeting sponsored by Acromegaly Community Inc., a patient support organization based in the US. The meeting will take
PWN at Spain’s 2019 Endocrinology Society Congress
December 20, 2019
From the desk of Jorge D Faccinetti, co-founder – The Spanish Society of Endocrinology or SEEN (Sociedad Española de Endocrinologia y Nutricion) had their annual conference – Congreso, in Spanish – this past October in Bilbao,
Risa’s story
December 17, 2019
From Jorge D Faccinetti, co-founder – Take the bull by the horns. This is an expression that most likely originated in the American West, where it was a common but dangerous practice to wrestle with